Gs. Wood et al., EXPRESSION OF CLASS-II MAJOR HISTOCOMPATIBILITY ANTIGENS BY KERATINOCYTES IN CUTANEOUS T-CELL LYMPHOMA, International journal of dermatology, 33(5), 1994, pp. 346-350
Background. Expression of various class II MHC antigens by lesional ke
ratinocytes may play an important role in the pathophysiology of a wid
e variety of human dermatoses including cutaneous T cell lymphoma (CTC
L). Nevertheless, there is relatively little information available con
cerning the concurrent expression Of HLA-DR, -DP, and -DQ class II MHC
antigens in CTCL. Therefore, our aim in this study was to determine t
he prevalence, localization, extent, temporal sequence, and consistenc
y of class II MHC antigen expression by lesional keratinocytes in CTCL
. Methods. We used a semiquantitative immunohistologic analysis to ana
lyze HLA-DR, -DP, and -DQ expression by lesional keratinocytes in 66 s
kin biopsies obtained from 39 patients with CTCL. Results. Class II MH
C antigen expression by keratinocytes was observed in 77% of cases. Ex
pression was detected on the cytoplasmic membrane and within the cytop
lasm. It varied among cases from focal to confluent. There was a hiera
rchy of antigen expression in terms of both extent and time course. HL
A-DR was expressed first and most extensively, followed by HLA-DP and
then HLA-DQ. Comparative studies of multiple serial or concurrent acti
ve lesions from 13 cases indicated that the overall pattern and extent
of antigen expression was relatively constant within individual patie
nts. Conclusions. There was no apparent correlation between class II M
HC antigen expression and the clinical stage of disease, the type of C
TCL skin lesion, or the overall density of the lesional T cell infiltr
ate. The hierarchy of keratinocyte class II MHC antigen expression obs
erved in this study paralleled that noted in earlier studies of cultur
ed keratinocytes exposed to recombinant interferon-gamma in vitro. Thi
s suggests that lesional cytokine levels may be the critical factor go
verning class II MHC antigen expression by lesional keratinocytes in C
TCL.